Karyopharm Therapeutics Inc KPTI:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 02/08/23 EST
3.44quote price arrow up+0.16 (+4.88%)
Volume
199,779
Close
3.28UNCH (UNCH)
Volume
2,088,359
52 week range
2.45 - 14.73
Loading...
  • Open3.55
  • Day High3.56
  • Day Low3.27
  • Prev Close3.28
  • 52 Week High14.73
  • 52 Week High Date02/18/22
  • 52 Week Low2.45
  • 52 Week Low Date12/27/22

Key Stats

  • Market Cap371.339M
  • Shares Out113.21M
  • 10 Day Average Volume1.92M
  • Dividend-
  • Dividend Yield-
  • Beta0.02
  • YTD % Change-3.53

KEY STATS

  • Open3.55
  • Day High3.56
  • Day Low3.27
  • Prev Close3.28
  • 52 Week High14.73
  • 52 Week High Date02/18/22
  • 52 Week Low2.45
  • 52 Week Low Date12/27/22
  • Market Cap371.339M
  • Shares Out113.21M
  • 10 Day Average Volume1.92M
  • Dividend-
  • Dividend Yield-
  • Beta0.02
  • YTD % Change-3.53

RATIOS/PROFITABILITY

  • EPS (TTM)-1.09
  • P/E (TTM)-3.01
  • Fwd P/E (NTM)-2.46
  • EBITDA (TTM)-60.724M
  • ROE (TTM)-891.04%
  • Revenue (TTM)249.763M
  • Gross Margin (TTM)98.36%
  • Net Margin (TTM)-35.26%
  • Debt To Equity (MRQ)-215.92%

EVENTS

  • Earnings Date05/03/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Karyopharm Therapeutics Inc

 

Profile

MORE
Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company. The Company is focused on the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. Its Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1 (CRM1). Its lead compound, XPOVIO (selinexor), is marketed in combination with Velcade (bortezomib) and...
Richard Paulson
President, Chief Executive Officer, Director
Michael Mason CPA
Chief Financial Officer, Senior Vice President, Treasurer
Stuart Poulton
Executive Vice President, Chief Development Officer
Address
85 Wells Ave
Newton Center, MA
02459-3298
United States

Top Peers

SYMBOLLASTCHG%CHG
PBYI
Puma Biotechnology Inc
4.62UNCHUNCH
MDXG
MiMedx Group Inc
4.49UNCHUNCH
AKBA
Akebia Therapeutics Inc
1.15UNCHUNCH
AVIR
Atea Pharmaceuticals Inc
4.38UNCHUNCH
MOR
MorphoSys AG
5.00UNCHUNCH